PROLOPA CAP 50-12.5
PROLOPA CAP 50-12.5
Approved
DIN Number
00522597
Drug Class
Human
Market Date
Dec 31, 1981
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00522597
AIG Number0211634003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N04BA02 LEVODOPA AND DECARBOXYLASE INHIBITOR
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:36.16
Health Canada Classification
ACTIVE INGREDIENTS (2)
BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE)Active
Strength: 12.5 MG
Monograph: BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE)
LEVODOPAActive
Strength: 50 MG
Monograph: LEVODOPA